Global Biodegradable Drug Eluting Stents Market Growth 2026-2032
The global Biodegradable Drug Eluting Stents market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Biodegradable Polymer Drug-eluting Stents (BP-DES) are medical devices used in the treatment of coronary artery disease. Unlike traditional stents that use permanent polymer coatings to release drugs, BP-DES incorporate biodegradable polymers that gradually degrade over time, leaving behind only the bare metal stent. These stents are designed to release drugs, typically anti-proliferative or anti-inflammatory agents, to prevent restenosis (re-narrowing of the artery) after angioplasty. The biodegradable polymer technology reduces the risk of long-term complications associated with permanent polymer stents, such as inflammation and late stent thrombosis, while still providing effective drug delivery to inhibit cell growth and maintain vessel patency.
United States market for Biodegradable Drug Eluting Stents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biodegradable Drug Eluting Stents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biodegradable Drug Eluting Stents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biodegradable Drug Eluting Stents players cover Boston Scientific, Biotronik, Biosensors International, TERUMO, MicroPort Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Biodegradable Drug Eluting Stents Industry Forecast? looks at past sales and reviews total world Biodegradable Drug Eluting Stents sales in 2025, providing a comprehensive analysis by region and market sector of projected Biodegradable Drug Eluting Stents sales for 2026 through 2032. With Biodegradable Drug Eluting Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biodegradable Drug Eluting Stents industry.
This Insight Report provides a comprehensive analysis of the global Biodegradable Drug Eluting Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biodegradable Drug Eluting Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biodegradable Drug Eluting Stents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biodegradable Drug Eluting Stents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biodegradable Drug Eluting Stents.
This report presents a comprehensive overview, market shares, and growth opportunities of Biodegradable Drug Eluting Stents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Biodegradable Polymer Drug-eluting Stents (BP-DES) are medical devices used in the treatment of coronary artery disease. Unlike traditional stents that use permanent polymer coatings to release drugs, BP-DES incorporate biodegradable polymers that gradually degrade over time, leaving behind only the bare metal stent. These stents are designed to release drugs, typically anti-proliferative or anti-inflammatory agents, to prevent restenosis (re-narrowing of the artery) after angioplasty. The biodegradable polymer technology reduces the risk of long-term complications associated with permanent polymer stents, such as inflammation and late stent thrombosis, while still providing effective drug delivery to inhibit cell growth and maintain vessel patency.
United States market for Biodegradable Drug Eluting Stents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Biodegradable Drug Eluting Stents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Biodegradable Drug Eluting Stents is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Biodegradable Drug Eluting Stents players cover Boston Scientific, Biotronik, Biosensors International, TERUMO, MicroPort Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Biodegradable Drug Eluting Stents Industry Forecast? looks at past sales and reviews total world Biodegradable Drug Eluting Stents sales in 2025, providing a comprehensive analysis by region and market sector of projected Biodegradable Drug Eluting Stents sales for 2026 through 2032. With Biodegradable Drug Eluting Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biodegradable Drug Eluting Stents industry.
This Insight Report provides a comprehensive analysis of the global Biodegradable Drug Eluting Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biodegradable Drug Eluting Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biodegradable Drug Eluting Stents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biodegradable Drug Eluting Stents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biodegradable Drug Eluting Stents.
This report presents a comprehensive overview, market shares, and growth opportunities of Biodegradable Drug Eluting Stents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 30 Days
- 60 Days
- 90 Days
- Direct Selling
- Distribution
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boston Scientific
- Biotronik
- Biosensors International
- TERUMO
- MicroPort Scientific
- Lepu Medical
- JW Medical
- SINOMED
- Bio-heart
- What is the 10-year outlook for the global Biodegradable Drug Eluting Stents market?
- What factors are driving Biodegradable Drug Eluting Stents market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Biodegradable Drug Eluting Stents market opportunities vary by end market size?
- How does Biodegradable Drug Eluting Stents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biodegradable Drug Eluting Stents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Biodegradable Drug Eluting Stents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Biodegradable Drug Eluting Stents by Country/Region, 2021, 2025 & 2032
2.2 Biodegradable Drug Eluting Stents Segment by Type
2.2.1 30 Days
2.2.2 60 Days
2.2.3 90 Days
2.2.4 Biodegradable Drug Eluting Stents Sales by Type
2.2.4.1 Global Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
2.2.4.2 Global Biodegradable Drug Eluting Stents Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Biodegradable Drug Eluting Stents Sale Price by Type (2021-2026)
2.3 Biodegradable Drug Eluting Stents Segment by Application
2.3.1 Direct Selling
2.3.2 Distribution
2.3.3 Biodegradable Drug Eluting Stents Sales by Application
2.3.3.1 Global Biodegradable Drug Eluting Stents Sale Market Share by Application (2021-2026)
2.3.3.2 Global Biodegradable Drug Eluting Stents Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Biodegradable Drug Eluting Stents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Biodegradable Drug Eluting Stents Breakdown Data by Company
3.1.1 Global Biodegradable Drug Eluting Stents Annual Sales by Company (2021-2026)
3.1.2 Global Biodegradable Drug Eluting Stents Sales Market Share by Company (2021-2026)
3.2 Global Biodegradable Drug Eluting Stents Annual Revenue by Company (2021-2026)
3.2.1 Global Biodegradable Drug Eluting Stents Revenue by Company (2021-2026)
3.2.2 Global Biodegradable Drug Eluting Stents Revenue Market Share by Company (2021-2026)
3.3 Global Biodegradable Drug Eluting Stents Sale Price by Company
3.4 Key Manufacturers Biodegradable Drug Eluting Stents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biodegradable Drug Eluting Stents Product Location Distribution
3.4.2 Players Biodegradable Drug Eluting Stents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIODEGRADABLE DRUG ELUTING STENTS BY GEOGRAPHIC REGION
4.1 World Historic Biodegradable Drug Eluting Stents Market Size by Geographic Region (2021-2026)
4.1.1 Global Biodegradable Drug Eluting Stents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Biodegradable Drug Eluting Stents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Biodegradable Drug Eluting Stents Market Size by Country/Region (2021-2026)
4.2.1 Global Biodegradable Drug Eluting Stents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Biodegradable Drug Eluting Stents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biodegradable Drug Eluting Stents Sales Growth
4.4 APAC Biodegradable Drug Eluting Stents Sales Growth
4.5 Europe Biodegradable Drug Eluting Stents Sales Growth
4.6 Middle East & Africa Biodegradable Drug Eluting Stents Sales Growth
5 AMERICAS
5.1 Americas Biodegradable Drug Eluting Stents Sales by Country
5.1.1 Americas Biodegradable Drug Eluting Stents Sales by Country (2021-2026)
5.1.2 Americas Biodegradable Drug Eluting Stents Revenue by Country (2021-2026)
5.2 Americas Biodegradable Drug Eluting Stents Sales by Type (2021-2026)
5.3 Americas Biodegradable Drug Eluting Stents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biodegradable Drug Eluting Stents Sales by Region
6.1.1 APAC Biodegradable Drug Eluting Stents Sales by Region (2021-2026)
6.1.2 APAC Biodegradable Drug Eluting Stents Revenue by Region (2021-2026)
6.2 APAC Biodegradable Drug Eluting Stents Sales by Type (2021-2026)
6.3 APAC Biodegradable Drug Eluting Stents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biodegradable Drug Eluting Stents by Country
7.1.1 Europe Biodegradable Drug Eluting Stents Sales by Country (2021-2026)
7.1.2 Europe Biodegradable Drug Eluting Stents Revenue by Country (2021-2026)
7.2 Europe Biodegradable Drug Eluting Stents Sales by Type (2021-2026)
7.3 Europe Biodegradable Drug Eluting Stents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biodegradable Drug Eluting Stents by Country
8.1.1 Middle East & Africa Biodegradable Drug Eluting Stents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Biodegradable Drug Eluting Stents Revenue by Country (2021-2026)
8.2 Middle East & Africa Biodegradable Drug Eluting Stents Sales by Type (2021-2026)
8.3 Middle East & Africa Biodegradable Drug Eluting Stents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biodegradable Drug Eluting Stents
10.3 Manufacturing Process Analysis of Biodegradable Drug Eluting Stents
10.4 Industry Chain Structure of Biodegradable Drug Eluting Stents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biodegradable Drug Eluting Stents Distributors
11.3 Biodegradable Drug Eluting Stents Customer
12 WORLD FORECAST REVIEW FOR BIODEGRADABLE DRUG ELUTING STENTS BY GEOGRAPHIC REGION
12.1 Global Biodegradable Drug Eluting Stents Market Size Forecast by Region
12.1.1 Global Biodegradable Drug Eluting Stents Forecast by Region (2027-2032)
12.1.2 Global Biodegradable Drug Eluting Stents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Biodegradable Drug Eluting Stents Forecast by Type (2027-2032)
12.7 Global Biodegradable Drug Eluting Stents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.1.3 Boston Scientific Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Biotronik
13.2.1 Biotronik Company Information
13.2.2 Biotronik Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.2.3 Biotronik Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Biotronik Main Business Overview
13.2.5 Biotronik Latest Developments
13.3 Biosensors International
13.3.1 Biosensors International Company Information
13.3.2 Biosensors International Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.3.3 Biosensors International Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Biosensors International Main Business Overview
13.3.5 Biosensors International Latest Developments
13.4 TERUMO
13.4.1 TERUMO Company Information
13.4.2 TERUMO Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.4.3 TERUMO Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 TERUMO Main Business Overview
13.4.5 TERUMO Latest Developments
13.5 MicroPort Scientific
13.5.1 MicroPort Scientific Company Information
13.5.2 MicroPort Scientific Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.5.3 MicroPort Scientific Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MicroPort Scientific Main Business Overview
13.5.5 MicroPort Scientific Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.6.3 Lepu Medical Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 JW Medical
13.7.1 JW Medical Company Information
13.7.2 JW Medical Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.7.3 JW Medical Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 JW Medical Main Business Overview
13.7.5 JW Medical Latest Developments
13.8 SINOMED
13.8.1 SINOMED Company Information
13.8.2 SINOMED Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.8.3 SINOMED Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 SINOMED Main Business Overview
13.8.5 SINOMED Latest Developments
13.9 Bio-heart
13.9.1 Bio-heart Company Information
13.9.2 Bio-heart Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.9.3 Bio-heart Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Bio-heart Main Business Overview
13.9.5 Bio-heart Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biodegradable Drug Eluting Stents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Biodegradable Drug Eluting Stents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Biodegradable Drug Eluting Stents by Country/Region, 2021, 2025 & 2032
2.2 Biodegradable Drug Eluting Stents Segment by Type
2.2.1 30 Days
2.2.2 60 Days
2.2.3 90 Days
2.2.4 Biodegradable Drug Eluting Stents Sales by Type
2.2.4.1 Global Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
2.2.4.2 Global Biodegradable Drug Eluting Stents Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Biodegradable Drug Eluting Stents Sale Price by Type (2021-2026)
2.3 Biodegradable Drug Eluting Stents Segment by Application
2.3.1 Direct Selling
2.3.2 Distribution
2.3.3 Biodegradable Drug Eluting Stents Sales by Application
2.3.3.1 Global Biodegradable Drug Eluting Stents Sale Market Share by Application (2021-2026)
2.3.3.2 Global Biodegradable Drug Eluting Stents Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Biodegradable Drug Eluting Stents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Biodegradable Drug Eluting Stents Breakdown Data by Company
3.1.1 Global Biodegradable Drug Eluting Stents Annual Sales by Company (2021-2026)
3.1.2 Global Biodegradable Drug Eluting Stents Sales Market Share by Company (2021-2026)
3.2 Global Biodegradable Drug Eluting Stents Annual Revenue by Company (2021-2026)
3.2.1 Global Biodegradable Drug Eluting Stents Revenue by Company (2021-2026)
3.2.2 Global Biodegradable Drug Eluting Stents Revenue Market Share by Company (2021-2026)
3.3 Global Biodegradable Drug Eluting Stents Sale Price by Company
3.4 Key Manufacturers Biodegradable Drug Eluting Stents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biodegradable Drug Eluting Stents Product Location Distribution
3.4.2 Players Biodegradable Drug Eluting Stents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BIODEGRADABLE DRUG ELUTING STENTS BY GEOGRAPHIC REGION
4.1 World Historic Biodegradable Drug Eluting Stents Market Size by Geographic Region (2021-2026)
4.1.1 Global Biodegradable Drug Eluting Stents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Biodegradable Drug Eluting Stents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Biodegradable Drug Eluting Stents Market Size by Country/Region (2021-2026)
4.2.1 Global Biodegradable Drug Eluting Stents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Biodegradable Drug Eluting Stents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biodegradable Drug Eluting Stents Sales Growth
4.4 APAC Biodegradable Drug Eluting Stents Sales Growth
4.5 Europe Biodegradable Drug Eluting Stents Sales Growth
4.6 Middle East & Africa Biodegradable Drug Eluting Stents Sales Growth
5 AMERICAS
5.1 Americas Biodegradable Drug Eluting Stents Sales by Country
5.1.1 Americas Biodegradable Drug Eluting Stents Sales by Country (2021-2026)
5.1.2 Americas Biodegradable Drug Eluting Stents Revenue by Country (2021-2026)
5.2 Americas Biodegradable Drug Eluting Stents Sales by Type (2021-2026)
5.3 Americas Biodegradable Drug Eluting Stents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biodegradable Drug Eluting Stents Sales by Region
6.1.1 APAC Biodegradable Drug Eluting Stents Sales by Region (2021-2026)
6.1.2 APAC Biodegradable Drug Eluting Stents Revenue by Region (2021-2026)
6.2 APAC Biodegradable Drug Eluting Stents Sales by Type (2021-2026)
6.3 APAC Biodegradable Drug Eluting Stents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Biodegradable Drug Eluting Stents by Country
7.1.1 Europe Biodegradable Drug Eluting Stents Sales by Country (2021-2026)
7.1.2 Europe Biodegradable Drug Eluting Stents Revenue by Country (2021-2026)
7.2 Europe Biodegradable Drug Eluting Stents Sales by Type (2021-2026)
7.3 Europe Biodegradable Drug Eluting Stents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biodegradable Drug Eluting Stents by Country
8.1.1 Middle East & Africa Biodegradable Drug Eluting Stents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Biodegradable Drug Eluting Stents Revenue by Country (2021-2026)
8.2 Middle East & Africa Biodegradable Drug Eluting Stents Sales by Type (2021-2026)
8.3 Middle East & Africa Biodegradable Drug Eluting Stents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biodegradable Drug Eluting Stents
10.3 Manufacturing Process Analysis of Biodegradable Drug Eluting Stents
10.4 Industry Chain Structure of Biodegradable Drug Eluting Stents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biodegradable Drug Eluting Stents Distributors
11.3 Biodegradable Drug Eluting Stents Customer
12 WORLD FORECAST REVIEW FOR BIODEGRADABLE DRUG ELUTING STENTS BY GEOGRAPHIC REGION
12.1 Global Biodegradable Drug Eluting Stents Market Size Forecast by Region
12.1.1 Global Biodegradable Drug Eluting Stents Forecast by Region (2027-2032)
12.1.2 Global Biodegradable Drug Eluting Stents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Biodegradable Drug Eluting Stents Forecast by Type (2027-2032)
12.7 Global Biodegradable Drug Eluting Stents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.1.3 Boston Scientific Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Biotronik
13.2.1 Biotronik Company Information
13.2.2 Biotronik Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.2.3 Biotronik Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Biotronik Main Business Overview
13.2.5 Biotronik Latest Developments
13.3 Biosensors International
13.3.1 Biosensors International Company Information
13.3.2 Biosensors International Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.3.3 Biosensors International Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Biosensors International Main Business Overview
13.3.5 Biosensors International Latest Developments
13.4 TERUMO
13.4.1 TERUMO Company Information
13.4.2 TERUMO Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.4.3 TERUMO Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 TERUMO Main Business Overview
13.4.5 TERUMO Latest Developments
13.5 MicroPort Scientific
13.5.1 MicroPort Scientific Company Information
13.5.2 MicroPort Scientific Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.5.3 MicroPort Scientific Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 MicroPort Scientific Main Business Overview
13.5.5 MicroPort Scientific Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.6.3 Lepu Medical Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 JW Medical
13.7.1 JW Medical Company Information
13.7.2 JW Medical Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.7.3 JW Medical Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 JW Medical Main Business Overview
13.7.5 JW Medical Latest Developments
13.8 SINOMED
13.8.1 SINOMED Company Information
13.8.2 SINOMED Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.8.3 SINOMED Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 SINOMED Main Business Overview
13.8.5 SINOMED Latest Developments
13.9 Bio-heart
13.9.1 Bio-heart Company Information
13.9.2 Bio-heart Biodegradable Drug Eluting Stents Product Portfolios and Specifications
13.9.3 Bio-heart Biodegradable Drug Eluting Stents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Bio-heart Main Business Overview
13.9.5 Bio-heart Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biodegradable Drug Eluting Stents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Biodegradable Drug Eluting Stents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30 Days
Table 4. Major Players of 60 Days
Table 5. Major Players of 90 Days
Table 6. Global Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 7. Global Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Table 8. Global Biodegradable Drug Eluting Stents Revenue by Type (2021-2026) & ($ million)
Table 9. Global Biodegradable Drug Eluting Stents Revenue Market Share by Type (2021-2026)
Table 10. Global Biodegradable Drug Eluting Stents Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Biodegradable Drug Eluting Stents Sale by Application (2021-2026) & (Units)
Table 12. Global Biodegradable Drug Eluting Stents Sale Market Share by Application (2021-2026)
Table 13. Global Biodegradable Drug Eluting Stents Revenue by Application (2021-2026) & ($ million)
Table 14. Global Biodegradable Drug Eluting Stents Revenue Market Share by Application (2021-2026)
Table 15. Global Biodegradable Drug Eluting Stents Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Biodegradable Drug Eluting Stents Sales by Company (2021-2026) & (Units)
Table 17. Global Biodegradable Drug Eluting Stents Sales Market Share by Company (2021-2026)
Table 18. Global Biodegradable Drug Eluting Stents Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Biodegradable Drug Eluting Stents Revenue Market Share by Company (2021-2026)
Table 20. Global Biodegradable Drug Eluting Stents Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Biodegradable Drug Eluting Stents Producing Area Distribution and Sales Area
Table 22. Players Biodegradable Drug Eluting Stents Products Offered
Table 23. Biodegradable Drug Eluting Stents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Biodegradable Drug Eluting Stents Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Biodegradable Drug Eluting Stents Sales Market Share Geographic Region (2021-2026)
Table 28. Global Biodegradable Drug Eluting Stents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Biodegradable Drug Eluting Stents Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Biodegradable Drug Eluting Stents Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Biodegradable Drug Eluting Stents Sales Market Share by Country/Region (2021-2026)
Table 32. Global Biodegradable Drug Eluting Stents Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Biodegradable Drug Eluting Stents Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Biodegradable Drug Eluting Stents Sales by Country (2021-2026) & (Units)
Table 35. Americas Biodegradable Drug Eluting Stents Sales Market Share by Country (2021-2026)
Table 36. Americas Biodegradable Drug Eluting Stents Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 38. Americas Biodegradable Drug Eluting Stents Sales by Application (2021-2026) & (Units)
Table 39. APAC Biodegradable Drug Eluting Stents Sales by Region (2021-2026) & (Units)
Table 40. APAC Biodegradable Drug Eluting Stents Sales Market Share by Region (2021-2026)
Table 41. APAC Biodegradable Drug Eluting Stents Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 43. APAC Biodegradable Drug Eluting Stents Sales by Application (2021-2026) & (Units)
Table 44. Europe Biodegradable Drug Eluting Stents Sales by Country (2021-2026) & (Units)
Table 45. Europe Biodegradable Drug Eluting Stents Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 47. Europe Biodegradable Drug Eluting Stents Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Biodegradable Drug Eluting Stents Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Biodegradable Drug Eluting Stents Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Biodegradable Drug Eluting Stents Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Biodegradable Drug Eluting Stents
Table 53. Key Market Challenges & Risks of Biodegradable Drug Eluting Stents
Table 54. Key Industry Trends of Biodegradable Drug Eluting Stents
Table 55. Biodegradable Drug Eluting Stents Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Biodegradable Drug Eluting Stents Distributors List
Table 58. Biodegradable Drug Eluting Stents Customer List
Table 59. Global Biodegradable Drug Eluting Stents Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Biodegradable Drug Eluting Stents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Biodegradable Drug Eluting Stents Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Biodegradable Drug Eluting Stents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Biodegradable Drug Eluting Stents Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Biodegradable Drug Eluting Stents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Biodegradable Drug Eluting Stents Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Biodegradable Drug Eluting Stents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Biodegradable Drug Eluting Stents Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Biodegradable Drug Eluting Stents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Biodegradable Drug Eluting Stents Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Biodegradable Drug Eluting Stents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Biodegradable Drug Eluting Stents Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Biodegradable Drug Eluting Stents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Boston Scientific Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 74. Boston Scientific Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 75. Boston Scientific Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Boston Scientific Main Business
Table 77. Boston Scientific Latest Developments
Table 78. Biotronik Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 79. Biotronik Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 80. Biotronik Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Biotronik Main Business
Table 82. Biotronik Latest Developments
Table 83. Biosensors International Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 84. Biosensors International Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 85. Biosensors International Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Biosensors International Main Business
Table 87. Biosensors International Latest Developments
Table 88. TERUMO Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 89. TERUMO Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 90. TERUMO Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. TERUMO Main Business
Table 92. TERUMO Latest Developments
Table 93. MicroPort Scientific Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 94. MicroPort Scientific Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 95. MicroPort Scientific Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. MicroPort Scientific Main Business
Table 97. MicroPort Scientific Latest Developments
Table 98. Lepu Medical Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 99. Lepu Medical Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 100. Lepu Medical Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Lepu Medical Main Business
Table 102. Lepu Medical Latest Developments
Table 103. JW Medical Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 104. JW Medical Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 105. JW Medical Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. JW Medical Main Business
Table 107. JW Medical Latest Developments
Table 108. SINOMED Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 109. SINOMED Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 110. SINOMED Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. SINOMED Main Business
Table 112. SINOMED Latest Developments
Table 113. Bio-heart Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-heart Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 115. Bio-heart Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Bio-heart Main Business
Table 117. Bio-heart Latest Developments
Table 1. Biodegradable Drug Eluting Stents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Biodegradable Drug Eluting Stents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30 Days
Table 4. Major Players of 60 Days
Table 5. Major Players of 90 Days
Table 6. Global Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 7. Global Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Table 8. Global Biodegradable Drug Eluting Stents Revenue by Type (2021-2026) & ($ million)
Table 9. Global Biodegradable Drug Eluting Stents Revenue Market Share by Type (2021-2026)
Table 10. Global Biodegradable Drug Eluting Stents Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Biodegradable Drug Eluting Stents Sale by Application (2021-2026) & (Units)
Table 12. Global Biodegradable Drug Eluting Stents Sale Market Share by Application (2021-2026)
Table 13. Global Biodegradable Drug Eluting Stents Revenue by Application (2021-2026) & ($ million)
Table 14. Global Biodegradable Drug Eluting Stents Revenue Market Share by Application (2021-2026)
Table 15. Global Biodegradable Drug Eluting Stents Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Biodegradable Drug Eluting Stents Sales by Company (2021-2026) & (Units)
Table 17. Global Biodegradable Drug Eluting Stents Sales Market Share by Company (2021-2026)
Table 18. Global Biodegradable Drug Eluting Stents Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Biodegradable Drug Eluting Stents Revenue Market Share by Company (2021-2026)
Table 20. Global Biodegradable Drug Eluting Stents Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Biodegradable Drug Eluting Stents Producing Area Distribution and Sales Area
Table 22. Players Biodegradable Drug Eluting Stents Products Offered
Table 23. Biodegradable Drug Eluting Stents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Biodegradable Drug Eluting Stents Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Biodegradable Drug Eluting Stents Sales Market Share Geographic Region (2021-2026)
Table 28. Global Biodegradable Drug Eluting Stents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Biodegradable Drug Eluting Stents Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Biodegradable Drug Eluting Stents Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Biodegradable Drug Eluting Stents Sales Market Share by Country/Region (2021-2026)
Table 32. Global Biodegradable Drug Eluting Stents Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Biodegradable Drug Eluting Stents Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Biodegradable Drug Eluting Stents Sales by Country (2021-2026) & (Units)
Table 35. Americas Biodegradable Drug Eluting Stents Sales Market Share by Country (2021-2026)
Table 36. Americas Biodegradable Drug Eluting Stents Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 38. Americas Biodegradable Drug Eluting Stents Sales by Application (2021-2026) & (Units)
Table 39. APAC Biodegradable Drug Eluting Stents Sales by Region (2021-2026) & (Units)
Table 40. APAC Biodegradable Drug Eluting Stents Sales Market Share by Region (2021-2026)
Table 41. APAC Biodegradable Drug Eluting Stents Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 43. APAC Biodegradable Drug Eluting Stents Sales by Application (2021-2026) & (Units)
Table 44. Europe Biodegradable Drug Eluting Stents Sales by Country (2021-2026) & (Units)
Table 45. Europe Biodegradable Drug Eluting Stents Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 47. Europe Biodegradable Drug Eluting Stents Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Biodegradable Drug Eluting Stents Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Biodegradable Drug Eluting Stents Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Biodegradable Drug Eluting Stents Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Biodegradable Drug Eluting Stents Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Biodegradable Drug Eluting Stents
Table 53. Key Market Challenges & Risks of Biodegradable Drug Eluting Stents
Table 54. Key Industry Trends of Biodegradable Drug Eluting Stents
Table 55. Biodegradable Drug Eluting Stents Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Biodegradable Drug Eluting Stents Distributors List
Table 58. Biodegradable Drug Eluting Stents Customer List
Table 59. Global Biodegradable Drug Eluting Stents Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Biodegradable Drug Eluting Stents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Biodegradable Drug Eluting Stents Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Biodegradable Drug Eluting Stents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Biodegradable Drug Eluting Stents Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Biodegradable Drug Eluting Stents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Biodegradable Drug Eluting Stents Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Biodegradable Drug Eluting Stents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Biodegradable Drug Eluting Stents Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Biodegradable Drug Eluting Stents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Biodegradable Drug Eluting Stents Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Biodegradable Drug Eluting Stents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Biodegradable Drug Eluting Stents Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Biodegradable Drug Eluting Stents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Boston Scientific Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 74. Boston Scientific Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 75. Boston Scientific Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Boston Scientific Main Business
Table 77. Boston Scientific Latest Developments
Table 78. Biotronik Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 79. Biotronik Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 80. Biotronik Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Biotronik Main Business
Table 82. Biotronik Latest Developments
Table 83. Biosensors International Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 84. Biosensors International Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 85. Biosensors International Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Biosensors International Main Business
Table 87. Biosensors International Latest Developments
Table 88. TERUMO Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 89. TERUMO Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 90. TERUMO Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. TERUMO Main Business
Table 92. TERUMO Latest Developments
Table 93. MicroPort Scientific Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 94. MicroPort Scientific Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 95. MicroPort Scientific Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. MicroPort Scientific Main Business
Table 97. MicroPort Scientific Latest Developments
Table 98. Lepu Medical Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 99. Lepu Medical Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 100. Lepu Medical Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Lepu Medical Main Business
Table 102. Lepu Medical Latest Developments
Table 103. JW Medical Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 104. JW Medical Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 105. JW Medical Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. JW Medical Main Business
Table 107. JW Medical Latest Developments
Table 108. SINOMED Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 109. SINOMED Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 110. SINOMED Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. SINOMED Main Business
Table 112. SINOMED Latest Developments
Table 113. Bio-heart Basic Information, Biodegradable Drug Eluting Stents Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-heart Biodegradable Drug Eluting Stents Product Portfolios and Specifications
Table 115. Bio-heart Biodegradable Drug Eluting Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Bio-heart Main Business
Table 117. Bio-heart Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biodegradable Drug Eluting Stents
Figure 2. Biodegradable Drug Eluting Stents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biodegradable Drug Eluting Stents Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Biodegradable Drug Eluting Stents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Biodegradable Drug Eluting Stents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Biodegradable Drug Eluting Stents Sales Market Share by Country/Region (2025)
Figure 10. Biodegradable Drug Eluting Stents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30 Days
Figure 12. Product Picture of 60 Days
Figure 13. Product Picture of 90 Days
Figure 14. Global Biodegradable Drug Eluting Stents Sales Market Share by Type in 2026
Figure 15. Global Biodegradable Drug Eluting Stents Revenue Market Share by Type (2021-2026)
Figure 16. Biodegradable Drug Eluting Stents Consumed in Direct Selling
Figure 17. Global Biodegradable Drug Eluting Stents Market: Direct Selling (2021-2026) & (Units)
Figure 18. Biodegradable Drug Eluting Stents Consumed in Distribution
Figure 19. Global Biodegradable Drug Eluting Stents Market: Distribution (2021-2026) & (Units)
Figure 20. Global Biodegradable Drug Eluting Stents Sale Market Share by Application (2025)
Figure 21. Global Biodegradable Drug Eluting Stents Revenue Market Share by Application in 2026
Figure 22. Biodegradable Drug Eluting Stents Sales by Company in 2026 (Units)
Figure 23. Global Biodegradable Drug Eluting Stents Sales Market Share by Company in 2026
Figure 24. Biodegradable Drug Eluting Stents Revenue by Company in 2026 ($ millions)
Figure 25. Global Biodegradable Drug Eluting Stents Revenue Market Share by Company in 2026
Figure 26. Global Biodegradable Drug Eluting Stents Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Biodegradable Drug Eluting Stents Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Biodegradable Drug Eluting Stents Sales 2021-2026 (Units)
Figure 29. Americas Biodegradable Drug Eluting Stents Revenue 2021-2026 ($ millions)
Figure 30. APAC Biodegradable Drug Eluting Stents Sales 2021-2026 (Units)
Figure 31. APAC Biodegradable Drug Eluting Stents Revenue 2021-2026 ($ millions)
Figure 32. Europe Biodegradable Drug Eluting Stents Sales 2021-2026 (Units)
Figure 33. Europe Biodegradable Drug Eluting Stents Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Biodegradable Drug Eluting Stents Sales 2021-2026 (Units)
Figure 35. Middle East & Africa Biodegradable Drug Eluting Stents Revenue 2021-2026 ($ millions)
Figure 36. Americas Biodegradable Drug Eluting Stents Sales Market Share by Country in 2026
Figure 37. Americas Biodegradable Drug Eluting Stents Revenue Market Share by Country (2021-2026)
Figure 38. Americas Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Figure 39. Americas Biodegradable Drug Eluting Stents Sales Market Share by Application (2021-2026)
Figure 40. United States Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Biodegradable Drug Eluting Stents Sales Market Share by Region in 2026
Figure 45. APAC Biodegradable Drug Eluting Stents Revenue Market Share by Region (2021-2026)
Figure 46. APAC Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Figure 47. APAC Biodegradable Drug Eluting Stents Sales Market Share by Application (2021-2026)
Figure 48. China Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 52. India Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Biodegradable Drug Eluting Stents Sales Market Share by Country in 2026
Figure 56. Europe Biodegradable Drug Eluting Stents Revenue Market Share by Country (2021-2026)
Figure 57. Europe Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Figure 58. Europe Biodegradable Drug Eluting Stents Sales Market Share by Application (2021-2026)
Figure 59. Germany Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 60. France Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Biodegradable Drug Eluting Stents Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Biodegradable Drug Eluting Stents Sales Market Share by Application (2021-2026)
Figure 67. Egypt Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Biodegradable Drug Eluting Stents in 2026
Figure 73. Manufacturing Process Analysis of Biodegradable Drug Eluting Stents
Figure 74. Industry Chain Structure of Biodegradable Drug Eluting Stents
Figure 75. Channels of Distribution
Figure 76. Global Biodegradable Drug Eluting Stents Sales Market Forecast by Region (2027-2032)
Figure 77. Global Biodegradable Drug Eluting Stents Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Biodegradable Drug Eluting Stents Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Biodegradable Drug Eluting Stents Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Biodegradable Drug Eluting Stents Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Biodegradable Drug Eluting Stents Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Biodegradable Drug Eluting Stents
Figure 2. Biodegradable Drug Eluting Stents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biodegradable Drug Eluting Stents Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Biodegradable Drug Eluting Stents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Biodegradable Drug Eluting Stents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Biodegradable Drug Eluting Stents Sales Market Share by Country/Region (2025)
Figure 10. Biodegradable Drug Eluting Stents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30 Days
Figure 12. Product Picture of 60 Days
Figure 13. Product Picture of 90 Days
Figure 14. Global Biodegradable Drug Eluting Stents Sales Market Share by Type in 2026
Figure 15. Global Biodegradable Drug Eluting Stents Revenue Market Share by Type (2021-2026)
Figure 16. Biodegradable Drug Eluting Stents Consumed in Direct Selling
Figure 17. Global Biodegradable Drug Eluting Stents Market: Direct Selling (2021-2026) & (Units)
Figure 18. Biodegradable Drug Eluting Stents Consumed in Distribution
Figure 19. Global Biodegradable Drug Eluting Stents Market: Distribution (2021-2026) & (Units)
Figure 20. Global Biodegradable Drug Eluting Stents Sale Market Share by Application (2025)
Figure 21. Global Biodegradable Drug Eluting Stents Revenue Market Share by Application in 2026
Figure 22. Biodegradable Drug Eluting Stents Sales by Company in 2026 (Units)
Figure 23. Global Biodegradable Drug Eluting Stents Sales Market Share by Company in 2026
Figure 24. Biodegradable Drug Eluting Stents Revenue by Company in 2026 ($ millions)
Figure 25. Global Biodegradable Drug Eluting Stents Revenue Market Share by Company in 2026
Figure 26. Global Biodegradable Drug Eluting Stents Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Biodegradable Drug Eluting Stents Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Biodegradable Drug Eluting Stents Sales 2021-2026 (Units)
Figure 29. Americas Biodegradable Drug Eluting Stents Revenue 2021-2026 ($ millions)
Figure 30. APAC Biodegradable Drug Eluting Stents Sales 2021-2026 (Units)
Figure 31. APAC Biodegradable Drug Eluting Stents Revenue 2021-2026 ($ millions)
Figure 32. Europe Biodegradable Drug Eluting Stents Sales 2021-2026 (Units)
Figure 33. Europe Biodegradable Drug Eluting Stents Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Biodegradable Drug Eluting Stents Sales 2021-2026 (Units)
Figure 35. Middle East & Africa Biodegradable Drug Eluting Stents Revenue 2021-2026 ($ millions)
Figure 36. Americas Biodegradable Drug Eluting Stents Sales Market Share by Country in 2026
Figure 37. Americas Biodegradable Drug Eluting Stents Revenue Market Share by Country (2021-2026)
Figure 38. Americas Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Figure 39. Americas Biodegradable Drug Eluting Stents Sales Market Share by Application (2021-2026)
Figure 40. United States Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Biodegradable Drug Eluting Stents Sales Market Share by Region in 2026
Figure 45. APAC Biodegradable Drug Eluting Stents Revenue Market Share by Region (2021-2026)
Figure 46. APAC Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Figure 47. APAC Biodegradable Drug Eluting Stents Sales Market Share by Application (2021-2026)
Figure 48. China Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 52. India Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Biodegradable Drug Eluting Stents Sales Market Share by Country in 2026
Figure 56. Europe Biodegradable Drug Eluting Stents Revenue Market Share by Country (2021-2026)
Figure 57. Europe Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Figure 58. Europe Biodegradable Drug Eluting Stents Sales Market Share by Application (2021-2026)
Figure 59. Germany Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 60. France Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Biodegradable Drug Eluting Stents Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Biodegradable Drug Eluting Stents Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Biodegradable Drug Eluting Stents Sales Market Share by Application (2021-2026)
Figure 67. Egypt Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Biodegradable Drug Eluting Stents Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Biodegradable Drug Eluting Stents in 2026
Figure 73. Manufacturing Process Analysis of Biodegradable Drug Eluting Stents
Figure 74. Industry Chain Structure of Biodegradable Drug Eluting Stents
Figure 75. Channels of Distribution
Figure 76. Global Biodegradable Drug Eluting Stents Sales Market Forecast by Region (2027-2032)
Figure 77. Global Biodegradable Drug Eluting Stents Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Biodegradable Drug Eluting Stents Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Biodegradable Drug Eluting Stents Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Biodegradable Drug Eluting Stents Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Biodegradable Drug Eluting Stents Revenue Market Share Forecast by Application (2027-2032)
